These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23455629)

  • 1. A large prospective European cohort study of patients treated with strontium ranelate and followed up over 3 years.
    Audran M; Jakob FJ; Palacios S; Brandi ML; Bröll H; Hamdy NA; McCloskey EV
    Rheumatol Int; 2013 Sep; 33(9):2231-9. PubMed ID: 23455629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strontium ranelate for preventing and treating postmenopausal osteoporosis.
    O'Donnell S; Cranney A; Wells GA; Adachi JD; Reginster JY
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005326. PubMed ID: 16856092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis.
    Meunier PJ; Roux C; Ortolani S; Diaz-Curiel M; Compston J; Marquis P; Cormier C; Isaia G; Badurski J; Wark JD; Collette J; Reginster JY
    Osteoporos Int; 2009 Oct; 20(10):1663-73. PubMed ID: 19153678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
    Reginster JY; Felsenberg D; Boonen S; Diez-Perez A; Rizzoli R; Brandi ML; Spector TD; Brixen K; Goemaere S; Cormier C; Balogh A; Delmas PD; Meunier PJ
    Arthritis Rheum; 2008 Jun; 58(6):1687-95. PubMed ID: 18512789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of 2 g/day of strontium ranelate in Asian women with postmenopausal osteoporosis.
    Liu JM; Wai-Chee Kung A; Pheng CS; Zhu HM; Zhang ZL; Wu YY; Xu L; Meng XW; Huang ML; Chung LP; Hussain NH; Sufian SS; Chen JL
    Bone; 2009 Sep; 45(3):460-5. PubMed ID: 19464401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.
    Reginster JY; Seeman E; De Vernejoul MC; Adami S; Compston J; Phenekos C; Devogelaer JP; Curiel MD; Sawicki A; Goemaere S; Sorensen OH; Felsenberg D; Meunier PJ
    J Clin Endocrinol Metab; 2005 May; 90(5):2816-22. PubMed ID: 15728210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of strontium ranelate on markers of cardiovascular risk in postmenopausal osteoporotic women.
    Atteritano M; Catalano A; Santoro D; Lasco A; Benvenga S
    Endocrine; 2016 Jul; 53(1):305-12. PubMed ID: 26304851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years.
    Reginster JY; Bruyère O; Sawicki A; Roces-Varela A; Fardellone P; Roberts A; Devogelaer JP
    Bone; 2009 Dec; 45(6):1059-64. PubMed ID: 19679207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men.
    Kaufman JM; Audran M; Bianchi G; Braga V; Diaz-Curiel M; Francis RM; Goemaere S; Josse R; Palacios S; Ringe JD; Felsenberg D; Boonen S
    J Clin Endocrinol Metab; 2013 Feb; 98(2):592-601. PubMed ID: 23341486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.
    Adami S
    Bone; 2006 Feb; 38(2 Suppl 1):23-7. PubMed ID: 16434247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strontium ranelate: vertebral and non-vertebral fracture risk reduction.
    Seeman E
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S17-20. PubMed ID: 16735841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strontium ranelate related Stevens-Johnson syndrome: a case report.
    Yang CY; Chen CH; Wang HY; Hsiao HL; Hsiao YH; Chung WH
    Osteoporos Int; 2014 Jun; 25(6):1813-6. PubMed ID: 24687387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strontium ranelate: a new paradigm in the treatment of osteoporosis.
    Reginster JY; Deroisy R; Jupsin I
    Drugs Today (Barc); 2003 Feb; 39(2):89-101. PubMed ID: 12698204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spotlight on strontium ranelate: in postmenopausal osteoporosis.
    Deeks ED; Dhillon S
    Drugs Aging; 2010 Sep; 27(9):771-3. PubMed ID: 20809666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of venous thromboembolism in users of strontium ranelate: an analysis of data from a prescription-event monitoring study in England.
    Osborne V; Layton D; Perrio M; Wilton L; Shakir SA
    Drug Saf; 2010 Jul; 33(7):579-91. PubMed ID: 20553059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strontium ranelate: a review of its use in the treatment of postmenopausal osteoporosis.
    Deeks ED; Dhillon S
    Drugs; 2010 Apr; 70(6):733-59. PubMed ID: 20394457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strontium ranelate for the management of osteoporosis.
    Lam S; Zouzias K
    Consult Pharm; 2008 Jul; 23(7):531-7. PubMed ID: 18764671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.
    Meunier PJ; Roux C; Seeman E; Ortolani S; Badurski JE; Spector TD; Cannata J; Balogh A; Lemmel EM; Pors-Nielsen S; Rizzoli R; Genant HK; Reginster JY
    N Engl J Med; 2004 Jan; 350(5):459-68. PubMed ID: 14749454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis.
    Borgström F; Ström O; Coelho J; Johansson H; Oden A; McCloskey E; Kanis JA
    Osteoporos Int; 2010 Feb; 21(2):339-49. PubMed ID: 19513577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX(®).
    Kanis JA; Johansson H; Oden A; McCloskey EV
    Osteoporos Int; 2011 Aug; 22(8):2347-55. PubMed ID: 21287148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.